Patent & IP news for April 16, 2016

35 U.S.C. §101 and the presumption of validity, and the effect on 12(b)(6) Motions from dunlapcodding.com

Julie Langdon

With the number of patents being invalidated under 35 U.S.C. § 101 on Motions to Dismiss after Mayo and Alice, there’s a fair question – what happened to the presumption of validity ...

Share via E–mail | Twitter | Facebook

Teva has new drug composition for treating multiple sclerosis [MS] from ipbiz.blogspot.com

Business-standard reports on a patent application from Teva related to a new MS drug:


The patent application, titled Stable Laquinimod Preparations, is for a pharmaceutical composition comprising laquinimod or a pharmaceutically acceptable salt of it ...

Share via E–mail | Twitter | Facebook

IPBiz from ipbiz.blogspot.com



The National Law Review has some advice for patent drafters [ Key Lessons from Patent Litigation for Drafting and Prosecuting Utility Patent Applications ], which includes this puzzling text:


The claimed invention should be sufficiently described in ...

Share via E–mail | Twitter | Facebook